281 related articles for article (PubMed ID: 16647712)
1. A modified alpha-galactosyl ceramide for staining and stimulating natural killer T cells.
Liu Y; Goff RD; Zhou D; Mattner J; Sullivan BA; Khurana A; Cantu C; Ravkov EV; Ibegbu CC; Altman JD; Teyton L; Bendelac A; Savage PB
J Immunol Methods; 2006 May; 312(1-2):34-9. PubMed ID: 16647712
[TBL] [Abstract][Full Text] [Related]
2. Novel synthesis of alpha-galactosyl-ceramides and confirmation of their powerful NKT cell agonist activity.
Lee A; Farrand KJ; Dickgreber N; Hayman CM; Jürs S; Hermans IF; Painter GF
Carbohydr Res; 2006 Dec; 341(17):2785-98. PubMed ID: 17014832
[TBL] [Abstract][Full Text] [Related]
3. Effects of lipid chain lengths in alpha-galactosylceramides on cytokine release by natural killer T cells.
Goff RD; Gao Y; Mattner J; Zhou D; Yin N; Cantu C; Teyton L; Bendelac A; Savage PB
J Am Chem Soc; 2004 Oct; 126(42):13602-3. PubMed ID: 15493902
[TBL] [Abstract][Full Text] [Related]
4. RCAI-8, 9, 18, 19, and 49-52, conformationally restricted analogues of KRN7000 with an azetidine or a pyrrolidine ring: Their synthesis and bioactivity for mouse natural killer T cells to produce cytokines.
Fuhshuku K; Hongo N; Tashiro T; Masuda Y; Nakagawa R; Seino K; Taniguchi M; Mori K
Bioorg Med Chem; 2008 Jan; 16(2):950-64. PubMed ID: 17950609
[TBL] [Abstract][Full Text] [Related]
5. Structure-based discovery of glycolipids for CD1d-mediated NKT cell activation: tuning the adjuvant versus immunosuppression activity.
Fujio M; Wu D; Garcia-Navarro R; Ho DD; Tsuji M; Wong CH
J Am Chem Soc; 2006 Jul; 128(28):9022-3. PubMed ID: 16834361
[TBL] [Abstract][Full Text] [Related]
6. The synthesis and in vivo evaluation of 2',2'-difluoro KRN7000.
Leung L; Tomassi C; Van Beneden K; Decruy T; Trappeniers M; Elewaut D; Gao Y; Elliott T; Al-Shamkhani A; Ottensmeier C; Werner JM; Williams A; Van Calenbergh S; Linclau B
ChemMedChem; 2009 Mar; 4(3):329-34. PubMed ID: 19137519
[TBL] [Abstract][Full Text] [Related]
7. The immunoregulatory role of CD1d-restricted natural killer T cells in disease.
van der Vliet HJ; Molling JW; von Blomberg BM; Nishi N; Kölgen W; van den Eertwegh AJ; Pinedo HM; Giaccone G; Scheper RJ
Clin Immunol; 2004 Jul; 112(1):8-23. PubMed ID: 15207777
[TBL] [Abstract][Full Text] [Related]
8. [A specific ligand of V alpha 14 NKT cells and its presentation].
Harada M; Taniguchi M
Tanpakushitsu Kakusan Koso; 2003 Jun; 48(8 Suppl):1126-32. PubMed ID: 12807019
[No Abstract] [Full Text] [Related]
9. Syntheses of biotinylated alpha-galactosylceramides and their effects on the immune system and CD1 molecules.
Sakai T; Naidenko OV; Iijima H; Kronenberg M; Koezuka Y
J Med Chem; 1999 May; 42(10):1836-41. PubMed ID: 10346936
[TBL] [Abstract][Full Text] [Related]
10. [Anti-tumor activity of KRN7000, an alpha-galactosylceramide and its action mechanism].
Kobayashi E; Koezuka Y
Tanpakushitsu Kakusan Koso; 2000 Apr; 45(6 Suppl):1193-8. PubMed ID: 10771695
[No Abstract] [Full Text] [Related]
11. CD1d-restricted NKT cell activation enhanced homeostatic proliferation of CD8+ T cells in a manner dependent on IL-4.
Ueda N; Kuki H; Kamimura D; Sawa S; Seino K; Tashiro T; Fushuku K; Taniguchi M; Hirano T; Murakami M
Int Immunol; 2006 Sep; 18(9):1397-404. PubMed ID: 16914507
[TBL] [Abstract][Full Text] [Related]
12. Synthesis and biological evaluation of alpha-galactosylceramide (KRN7000) and isoglobotrihexosylceramide (iGb3).
Xia C; Yao Q; Schümann J; Rossy E; Chen W; Zhu L; Zhang W; De Libero G; Wang PG
Bioorg Med Chem Lett; 2006 Apr; 16(8):2195-9. PubMed ID: 16458002
[TBL] [Abstract][Full Text] [Related]
13. RCAI-17, 22, 24-26, 29, 31, 34-36, 38-40, and 88, the analogs of KRN7000 with a sulfonamide linkage: their synthesis and bioactivity for mouse natural killer T cells to produce Th2-biased cytokines.
Tashiro T; Hongo N; Nakagawa R; Seino K; Watarai H; Ishii Y; Taniguchi M; Mori K
Bioorg Med Chem; 2008 Oct; 16(19):8896-906. PubMed ID: 18790646
[TBL] [Abstract][Full Text] [Related]
14. The crystal structure of human CD1d with and without alpha-galactosylceramide.
Koch M; Stronge VS; Shepherd D; Gadola SD; Mathew B; Ritter G; Fersht AR; Besra GS; Schmidt RR; Jones EY; Cerundolo V
Nat Immunol; 2005 Aug; 6(8):819-26. PubMed ID: 16007090
[TBL] [Abstract][Full Text] [Related]
15. Expansion of human Valpha24+ NKT cells by repeated stimulation with KRN7000.
Rogers PR; Matsumoto A; Naidenko O; Kronenberg M; Mikayama T; Kato S
J Immunol Methods; 2004 Feb; 285(2):197-214. PubMed ID: 14980434
[TBL] [Abstract][Full Text] [Related]
16. Synthesis of diglycosylceramides and evaluation of their iNKT cell stimulatory properties.
Liu Y; Deng S; Bai L; Freigang S; Mattner J; Teyton L; Bendelac A; Savage PB
Bioorg Med Chem Lett; 2008 May; 18(10):3052-5. PubMed ID: 18206371
[TBL] [Abstract][Full Text] [Related]
17. Induction of Th1-biased cytokine production by alpha-carba-GalCer, a neoglycolipid ligand for NKT cells.
Tashiro T; Sekine-Kondo E; Shigeura T; Nakagawa R; Inoue S; Omori-Miyake M; Chiba T; Hongo N; Fujii S; Shimizu K; Yoshiga Y; Sumida T; Mori K; Watarai H; Taniguchi M
Int Immunol; 2010 Apr; 22(4):319-28. PubMed ID: 20181652
[TBL] [Abstract][Full Text] [Related]
18. [Repeated administration of alpha-galactosyl ceramide attenuates of natural killer T cells].
Minagawa M; Iiai T; Sato Y; Yamamoto S; Hatakeyama K
Gan To Kagaku Ryoho; 2005 Oct; 32(11):1553-5. PubMed ID: 16315866
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and evaluation of 1,2,3-triazole containing analogues of the immunostimulant alpha-GalCer.
Lee T; Cho M; Ko SY; Youn HJ; Baek DJ; Cho WJ; Kang CY; Kim S
J Med Chem; 2007 Feb; 50(3):585-9. PubMed ID: 17266209
[TBL] [Abstract][Full Text] [Related]
20. The in vivo response of invariant natural killer T cells to glycolipid antigens.
Parekh VV; Lalani S; Van Kaer L
Int Rev Immunol; 2007; 26(1-2):31-48. PubMed ID: 17454263
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
